Patents by Inventor Philipp Groene

Philipp Groene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETECTING AND MONITORING ORAL ANTICOAGULANTS OR INTRAVENOUS DIRECT THROMBIN INHIBITORS IN A BLOOD SAMPLE
    Publication number: 20240379198
    Abstract: An example method detecting a presence of one or more oral anticoagulants or intravenous (IV) direct thrombin inhibitors in a blood sample may include the following operations: receiving parameters that are based on viscoelastic tests; comparing the parameters to predefined threshold values, where the parameters and the predefined threshold values are based on an identity of the one or more oral anticoagulants or the IV direct thrombin inhibitors; and detecting, based on the comparing, the presence of the one or more oral anticoagulants or IV direct thrombin inhibitors in the blood sample. The viscoelastic tests are performed on portions of the blood sample to obtain the parameters. The viscoelastic tests include both a viscoelastic test based on Ecarin activation and a viscoelastic test with low tissue factor activation.
    Type: Application
    Filed: July 24, 2024
    Publication date: November 14, 2024
    Applicant: Instrumentation Laboratory Company
    Inventors: Simon Schäfer, Philipp Groene, Klaus Görlinger
  • Detecting and monitoring oral anticoagulants or intravenous direct thrombin inhibitors in a blood sample
    Patent number: 12073926
    Abstract: An example method detecting a presence of one or more oral anticoagulants or intravenous (IV) direct thrombin inhibitors in a blood sample may include the following operations: receiving parameters that are based on viscoelastic tests; comparing the parameters to predefined threshold values, where the parameters and the predefined threshold values are based on an identity of the one or more oral anticoagulants or the IV direct thrombin inhibitors; and detecting, based on the comparing, the presence of the one or more oral anticoagulants or IV direct thrombin inhibitors in the blood sample. The viscoelastic tests are performed on portions of the blood sample to obtain the parameters. The viscoelastic tests include both a viscoelastic test based on Ecarin activation and a viscoelastic test with low tissue factor activation.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: August 27, 2024
    Assignee: Instrumentation Laboratory Company
    Inventors: Simon Schäfer, Philipp Groene, Klaus Görlinger
  • DETECTING AND MONITORING ORAL ANTICOAGULANTS OR INTRAVENOUS DIRECT THROMBIN INHIBITORS IN A BLOOD SAMPLE
    Publication number: 20220093223
    Abstract: An example method detecting a presence of one or more oral anticoagulants or intravenous (IV) direct thrombin inhibitors in a blood sample may include the following operations: receiving parameters that are based on viscoelastic tests; comparing the parameters to predefined threshold values, where the parameters and the predefined threshold values are based on an identity of the one or more oral anticoagulants or the IV direct thrombin inhibitors; and detecting, based on the comparing, the presence of the one or more oral anticoagulants or IV direct thrombin inhibitors in the blood sample. The viscoelastic tests are performed on portions of the blood sample to obtain the parameters. The viscoelastic tests include both a viscoelastic test based on Ecarin activation and a viscoelastic test with low tissue factor activation.
    Type: Application
    Filed: September 21, 2021
    Publication date: March 24, 2022
    Applicant: Instrumentation Laboratory Company
    Inventors: Simon Schäfer, Philipp Groene, Klaus Görlinger